Briefly, MDA can react with thiobarbituric acid (TBA) to generate the MDA-TBA adduct which can be measured spectrophotometrically at 532 nm
Symptoms tend to be worse at night and can include numbness, difficulty feeling pain or temperature changes, tingling or burning sensation, sharp pains, or cramps, increased sensitivity, or hypersensitivity to touch, muscle weakness, loss of reflexes, loss of balance and coordination, serious foot problems (ulcers, infections, deformities, bone and joint pain) - When affecting multiple nerves/nerve groups (polyneuropathy) or a single nerve/ nerve group mononeuropathy Common Medications: - Lyrica (pregabalin) - Neurontin (gabapentin) - Carbamazepine (off-label) -Duloxetine (off-label) Work Cited: Optum HCC Coder
See risk and side effect info here
Tirzepatide is also not just GLP-1. It is a dual GIP/GLP-1 receptor agonist
Neurobiological mechanisms suggest plausible pathways through which GLP-1 medications might influence food preferences
Focus on: legumes as protein source, tofu and tempeh prepared without excessive oil, quinoa and other whole grains, vegetables in abundance, and moderate amounts of nuts and seeds